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Abstract
Magnesium (Mg) plays an essential role in fundamental cellular reactions and the importance of the immuno-
inflammatory processes in the pathology of Mg deficiency has been recently reconsidered. The purpose of the present study
was to assess the effect of different stages of Mg deficiency on endotoxin response and tumor necrosis factor-K (TNFK)
production. Weaning male Wistar rats were pair fed either a Mg-deficient or a control diet. At day 7, lipopolysaccharide
(LPS) induced no lethal effects in control rats but resulted in 70% mortality in Mg-deficient rats within 3 h. The vulnerability
of Mg-deficient rats to LPS was associated with higher TNFK plasma values. Mg-deficient animals that received magnesium
supplementation before endotoxin challenge had significantly increased survival. At day 2, control and Mg-deficient rats
were also subjected to endotoxin challenge with or without magnesium pre-treatment. A significant increase in TNFK plasma
level was observed in Mg-deficient rats compared to rats fed the control diet. Mg-deficient rats that received magnesium
replacement therapy before endotoxin challenge had significantly lower TNFK plasma values than those receiving saline
before endotoxin. Thus, the results of this experiment suggest that the activated or primed state of immune cells is an early
event occurring in Mg deficiency. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Magnesium (Mg), the most abundant intracellular
divalent cation, plays an essential role in a wide
range of fundamental cellular reactions, and many
clinical signs, symptoms and disease states are attrib-
uted to altered Mg homeostasis [1]. In developed
countries, the marginal Mg intake may induce a
high prevalence of marginal Mg de¢ciency. Mg de-
pletion may also occur because of dysregulations of
control mechanisms of Mg metabolism [2]. Mg de¢-
ciency has been extensively studied in the rat where it
is readily produced by dietary depletion. In 1932,
Kruse et al. [3] reported peripheral vasodilatation
with hyperemia of the ears in rats following Mg de-
¢ciency. The importance of the immuno-in£amma-
tory processes in the pathobiology of Mg de¢ciency
has been recently reconsidered. The aim of several
studies has been to characterize more precisely this
0925-4439 / 99 / $ ^ see front matter ß 1999 Elsevier Science B.V. All rights reserved.
PII: S 0 9 2 5 - 4 4 3 9 ( 9 8 ) 0 0 0 8 1 - 7
Abbreviations: LPS, lipopolysaccharide; TNFK, tumor ne-
crosis factor-K
* Corresponding author. Fax: +33 (4) 73624238;
E-mail : u3m@clermont.inra.fr
1 Present address: Veterinary Faculty, Academy of Agricul-
ture, Norwida St 29, 5035 Wroclaw, Poland.
BBADIS 61785 23-12-98
Biochimica et Biophysica Acta 1453 (1999) 35^40
in£ammatory response [4,5] which results in signi¢-
cant increase in free radical species [6^8] and subse-
quent tissue injury [9,10]. Moreover, Mg de¢ciency
aggravates endotoxin shock [4,11], but the mecha-
nism responsible for the detrimental e¡ect of Mg
de¢ciency on immune cells remains unknown. The
macrophage is a major e¡ector cell in the host re-
sponse to endotoxin [12] and tumor necrosis factor-K
(TNFK) has been implicated as an important medi-
ator in the development of endotoxin toxicity [13^
15]. Recent data from our group suggest that Mg
de¢ciency results in macrophage activation [4].
Thus, it is possible that TNFK is involved in produc-
ing a state of shock following lipopolysaccharide
(LPS) challenge. Other studies from our laboratory
demonstrate that early modi¢cations in the immune
system occur in Mg-de¢cient rats [16]. Therefore, the
purpose of the present study was to assess the e¡ects
of di¡erent stages of Mg de¢ciency on endotoxin
response and TNFK production.
2. Materials and methods
2.1. Animals, diets and treatment
Male weaning Wistar rats (I¡a-Credo, L’Arbresle,
France) weighing about 60 þ 2 g (mean þ S.E.M.)
were randomly divided into Mg-de¢cient and control
groups. The institution’s guide for the care and use
of laboratory animals was used. The rats were
housed in wire-bottomed cages in a temperature-con-
trolled room (22‡C) with a 12 h dark (20.00^08.00 h)
and 12 h light period. They were pair fed with the
appropriate diets for 8 days using an automatic feed-
ing apparatus. Distilled water was provided ad libi-
tum. The synthetic diets contained (g/kg): casein 200,
sucrose 650, corn oil 50, alphacel 50, DL-methionine
3, choline bitartrate 2, modi¢ed AIN-76 mineral mix
35, AIN-76A vitamin mix 10 (ICN Biomedicals, Or-
say, France). MgO was omitted from the AIN-min-
eral mix in Mg-de¢cient diet. The Mg concentrations
of the diets, determined by £ame atomic absorption
spectrometric analysis (Perkin Elmer 400, Norwalk,
CT), were 29 mg/kg (de¢cient diet) and 943 mg/kg
(control diet). Animals were anesthetized with so-
dium pentobarbital (40 mg/kg body weight, intraper-
itoneally). Blood was collected by exsanguination via
the abdominal aorta and plasma was obtained by
low-speed centrifugation (2000Ug) and stored at
380‡C until analysis.
LPS (Escherichia coli, 011: B4, Sigma, St Quentin
Fallavier, France) was dissolved in sterile saline im-
mediately before administration and rats received ei-
ther LPS (1 mg/kg intraperitoneally) or normal saline
solution. In experiments designed to assess the e¡ects
of acute Mg supplementation on endotoxin response,
rats received 50 mg/kg MgCl2 intraperitoneally 30
min before the animals were challenged with LPS.
Animals were maintained on the experimental diet
for either 2 or 7 days before experimentation.
Day 7: rats were sacri¢ced for assessment of Mg
status (eight animals for each dietary group), or sub-
jected to endotoxin challenge. At day 7 the behavior
of the animals was observed 180 min after endotoxin
administration to assess the e¡ect of Mg status on
mortality (24 animals for each dietary group) or sac-
ri¢ced 90 min after administration of endotoxin or
normal saline solution (24 animals for each dietary
group). An additional Mg-de¢cient group was used
to evaluate the e⁄ciency of acute Mg therapy on
response of Mg-de¢cient rats to endotoxin challenge
(12 animals for each group). Day 2: rats were ob-
served 180 min after endotoxin administration (12
animals for each dietary group) or sacri¢ced 90
min after endotoxin challenge with or without Mg
pre-treatment (ten animals for each group) for blood
plasma Mg and TNFK determination.
2.2. Analysis
Leukocyte number was determined by a cell coun-
ter (Cobas, Ho¡mann La Roche). Plasma was deter-
mined by £ame atomic absorption spectrometry
analysis (Perkin Elmer 420) after dilution in lantha-
num chloride solution containing 1 g La/l.
TNFK was measured in plasma samples by a cy-
totoxicity assay using L929 murine ¢broblasts [17].
Brie£y, after L929 cells were cultured in microtiter
plates for 20 h, diluted plasma samples or standards
were added in triplicate with actinomycin D (1 Wg/ml)
(Sigma, St Quentin Fallavier, France). Three serial
2-fold dilutions (from 1/32 to 1/128) were tested
for each plasma samples. After 24 h incubation, the
cells were stained with 0.5% crystal violet in ethanol-
H2O (1:5) and washed. A microtiter plate was used
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for measurement. TNFK activity was expressed in
pg/ml. The assay was calibrated using murine re-
combinant TNFK (National Institute for Biological
Standards and Controls, NIBSC, 88/532, Hertford-
shire, UK).
2.3. Statistical methods
Results are expressed as means þ S.E.M. The stat-
istical signi¢cance of di¡erences was assessed using
Student’s t-test, and ANOVA with the StatView 512,
statistical software. When signi¢cant di¡erences be-
tween groups were identi¢ed (P6 0.05), comparisons
between individuals groups were made using Tukey’s
test. Survival data after LPS challenge were analyzed
using chi-square analysis with the Instat statistical
program.
3. Results
The ¢rst set of experiments was performed on rats
fed the experimental diet for 7 days. Clinical symp-
toms including hyperemia, slight growth retardation,
leukocytosis, and decreased plasma Mg level indi-
cated that the rats fed the Mg-de¢cient diet were
indeed Mg-de¢cient (Table 1). LPS at 1 mg/kg in-
duced no lethal e¡ect in control rats but induced
the classical signs of shock and resulted in 70% mor-
tality in Mg-de¢cient rats within 3 h (P6 0.001, M2).
The TNFK level remained beneath the limit of detec-
tion in control and Mg-de¢cient rats before LPS in-
jection, but 90 min after endotoxin administration all
animals displayed a rise in plasma TNFK levels. Im-
portantly, higher plasma TNFK levels were found in
Mg-de¢cient rats compared to control rats (about
10-fold) (Table 2). Thus, Mg de¢ciency enhances
the animal’s sensitivity to endotoxin. Mg-de¢cient
animals that received Mg supplementation before en-
dotoxin challenge had a signi¢cantly increased sur-
vival rate compared to those receiving saline (Fig. 1)
(P6 0.001 M2). The possibility that modi¢cation of
immune response is an early event in Mg de¢ciency
was assessed in rats following 2 days of Mg depriva-
tion. Endotoxin administration did not result in mor-
tality of any rat that received experimental diets for
2 days. After endotoxin challenge, higher plasma
TNFK values were found in Mg-de¢cient rats than
in control rats. Mg-de¢cient rats that received Mg
supplementation before endotoxin challenge had sig-
ni¢cantly lower plasma TNFK values than animals
that received saline before endotoxin. However, there
were no signi¢cant di¡erences in plasma TNFK val-
Table 1
Body weights, plasma magnesium concentrations and leukocyto-




Body weight (g) 96 þ 2 91 þ 2
Plasma Mg (mmol/l) 0.81 þ 0.04 0.07 þ 0.01*
White blood cellsU106/ml 4.61 þ 0.87 20.04 þ 2.29*
Values are means þ S.E.M., n = 8. *P6 0.001: signi¢cant di¡er-
ence between control and Mg-de¢cient rats.
Fig. 1. Mortality after LPS challenge (1 mg/kg) with or without
magnesium pre-treatment (50 mg/kg MgCl2) in Mg-de¢cient
rats (12 per group) after 7 days on experimental diet. Mortality
rates di¡er signi¢cantly at P6 0.001 (chi-square test).
Table 2
Plasma TNFK concentrations, before or after LPS challenge, in





Without LPS n.d. n.d.
With LPS 341 þ 137 3109 þ 616*
Values are means þ S.E.M., n = 8. *P6 0.001: signi¢cant di¡er-
ence between control and Mg-de¢cient rats.
n.d., not detectable.
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ues between control animals that received Mg or
saline before endotoxin challenge (Table 3). Mg-de-
¢cient rats had decreased plasma Mg values com-
pared to controls. Furthermore, a signi¢cant increase
in plasma Mg values was noted in animals that re-
ceived Mg compared to baseline values (Table 3).
4. Discussion
Mg plays an important role in the maintenance of
host regulatory mechanisms in in£ammation. It is
well known that dietary Mg de¢ciency in the rat
gives rise, after a few days, to a characteristic periph-
eral vasodilatation. Leukocytosis, enlarged spleen
and exhaustive degranulation of mast cells have
also been reported [3,18]. More recent studies indi-
cate that Mg de¢ciency produces an elevation in
plasma in£ammatory cytokines [5,19,20] and nitric
oxide [21]. The increased circulating interleukin-6 in
Mg-de¢cient rats also induces the synthesis of acute
phase reactants [4]. Macrophages, found in greater
number in the peritoneal cavity of Mg-de¢cient
rats, appear to be primed for superoxide production
following phorbol myristate acetate stimulation [4],
i.e. these cells have enhanced response to stimulation.
Together, these results indicate that in Mg-de¢cient
rats the phagocytic cells are metabolically stimulated.
There is increasing evidence of the importance of a
cytokine cascade in the induction and control of the
in£ammatory reaction. It has been reported that the
increased production of free radicals in Mg de¢-
ciency is caused by elevated concentrations of
TNFK, which in turn was increased by early induc-
tion of substance P [5]. Increased TNFK concentra-
tions, however, were only detected after several
weeks of Mg de¢ciency [19,22]. In the present study,
after 1 week on Mg-de¢cient diet we were unable to
detect TNFK in the plasma of Mg-de¢cient rats de-
spite the high sensitivity of the bioassay used. After
LPS administration, TNFK is generated in su⁄cient
amounts to reach detectable levels in the blood of
control and Mg-de¢cient rats.
The major ¢nding of this study is that the vulner-
ability of Mg-de¢cient rats to LPS is associated with
higher production of TNFK and that this alteration
occurs as early as 48 h following the ¢rst Mg de-
pleted meal. The fact that after 2 days on magnesi-
um-de¢cient diet the higher production of TNFK
following LPS challenge is not followed by mortality
should be underlined, even though after 7 days of
Mg deprivation a higher mortality is observed after
LPS challenge. The mechanisms underlying septic
shock have been the subject of intensive investiga-
tions [23]. LPS induces a spectrum of pathophysio-
logical activities, many of which are strikingly similar
to those seen in patients with Gram-negative infec-
tion. Bacterial LPS reacts with plasma proteins and
with speci¢c cellular receptors initiating a response
by the host defence system to the invading Gram-
negative bacteria. However, in some situations, the
response to LPS may become detrimental to the host.
An intravenous injection of a su⁄cient amount of
LPS into an animal produces a severe clinical syn-
drome known as endotoxin shock [24]. The general-
ized vasodilatation produces hypotension and the
stimulated phagocytic cells release toxic reactive oxy-
gen intermediates and proteolytic enzymes resulting
in severe tissue damage. Many of these e¡ects are
mediated by endogenous cytokines. Although cyto-
kines are required for the in£ammatory process in
response to infection or injury, their overproduction
can lead to local and systemic pathology [25]. TNFK
is thought to be one of the important mediators in
Table 3
Plasma TNFK concentrations after magnesium or saline injection to control and Mg-de¢cient rats, after 2 days on experimental diets
Control Mg-de¢cient ANOVA
Saline Mg Saline Mg
Plasma Mg (mmol/l) 0.85 þ 0.05a 1.49 þ 0.05b 0.53 þ 0.04c 1.19 þ 0.06d D, T, DUT
Plasma TNFK (pg/ml) 1665 þ 463a 1821 þ 225a 4400 þ 798b 1712 þ 292a D, T, DUT
Values are means þ S.E.M., n = 8. Data were analyzed by two-way ANOVA to determine the e¡ect of diet (D), the e¡ect of Mg treat-
ment (T) and interaction (DUT).
Values with di¡erent superscripts are signi¢cantly di¡erent, P6 0.05.
BBADIS 61785 23-12-98
C. Malpuech-Bruge're et al. / Biochimica et Biophysica Acta 1453 (1999) 35^4038
septic shock [13^15]. And it has been shown that
TNFK can induce pathophysiological changes char-
acteristic of septic shock. Furthermore, a treatment
with TNFK antibodies has been shown to protect
against shocks induced by endotoxins [14]. The
present results clearly indicate that Mg-de¢cient
rats are hypersensitive to LPS as evidenced by the
level of lethality following 7 days of Mg deprivation.
The underlying mechanisms of the vulnerability of
Mg-de¢cient rats to LPS are unknown. Feeding the
animals with the Mg-de¢cient diet resulted in a rapid
decline in plasma Mg while the cellular concentration
of Mg falls only slightly in most tissues from these
animals [26]. Thus, the e¡ect of Mg de¢ciency on the
immune response is probably more related to the
reduction in the extracellular Mg concentration. In
agreement with this ¢nding is the result that high
mortality in Mg-de¢cient rats is reduced by paren-
teral Mg administration before LPS challenge. The
alteration of the e¡ects of Mg de¢ciency by Mg sup-
plementation also suggests that the bene¢cial e¡ect
of Mg is due to increased plasma concentrations.
Based on this concept one potential mechanism for
the e¡ect of Mg may be through its partial antago-
nism to calcium [27]. Previous studies have estab-
lished a role for calcium in the activation of immune
cells [28] and the results raise the possibility that
extracellular Mg exerts an inhibitory e¡ect on Ca
in£ux or Ca mobilization in immune cells.
Several studies have provided convincing evidence
for the role of TNFK as a mediator of septic shock.
For this reason, therapeutic interventions that de-
crease the level of cytokines have come to be of con-
siderable interest for controlling the sepsis syndrome
[29]. Our data suggest that plasma Mg levels may be
an important regulatory element in immune response
since supplemental Mg is able to reduce the secretion
of TNFK. Hypomagnesemia is a common electrolyte
disorder in hospitalized patients [30]. Sepsis and its
associated syndromes represent a potentially devas-
tating systemic in£ammatory response estimated to
occur in 1% of hospitalized patients. Mortality ap-
proaches 60^90% in those who develop septic shock
[31]. TNFK is released during the early stages of
septic shock. Circulating TNFK levels might corre-
late with outcome in severe sepsis [32^35]. Moreover,
recent re-evaluation of the clinical de¢nition of sepsis
has emphasized the importance of the host response
to the insult rather than the virulence of an infecting
organism. The exact relevance of the current study to
the potential bene¢t of Mg supplementation in pre-
venting septic shock is not entirely clear. However,
the present experiment indicates that a relatively ac-
tivated or primed state of LPS-induced TNFK pro-
duction is an early event occurring within the ¢rst
2 days of Mg deprivation.
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